Möchten Sie immer auf dem neuesten Stand bleiben?

Dublin, Sept. 30, 2025 (GLOBE NEWSWIRE) -- The "Germany Orthopedic Power Tools and Consumables Market Outlook" report has been added to ResearchAndMarkets.com's offering.This comprehensive databook...

HOUSTON, Sept. 22, 2025 (GLOBE NEWSWIRE) -- Baylor Genetics, a clinical diagnostic laboratory at the forefront of genetic testing, today announced it will showcase its leadership in pediatric...

HOUSTON, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Plains All American Pipeline, L.P. (Nasdaq: PAA) and Plains GP Holdings (Nasdaq: PAGP) today reported solid second-quarter 2025 results and provided the...

NEW YORK, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Arax Investment Partners (“Arax”), a premier wealth and asset management platform company backed by RedBird Capital Partners (“RedBird”), today announced...

WASHINGTON, D.C., July 31, 2025 (GLOBE NEWSWIRE) -- Children’s National Hospital welcomes Ethan Leonard, MD, MBA, as the new senior vice president for the Hospital Based Specialties (HBS) Center of...

BELLEVUE, Wash., July 14, 2025 (GLOBE NEWSWIRE) -- A groundbreaking study published today in Pediatrics Open Science shows a notable increase in the use of medication to treat pediatric obesity in...

Der Antrag basiert auf den Ergebnissen der Phase III-Studie AMPLITUDE, in der niraparib in Kombination mit abirateronacetat plus prednison oder prednisolon im Vergleich zur aktuellen Standardtherapie...

La demande est fondée sur les résultats de l’étude de la Phase 3 AMPLITUDE visant à évaluer le niraparib en association avec de l’acétate d’abiratérone et de la prednisone ou de la prednisolone...

PaymentWorks July 16th Live Event: Nacha Rule Changes - Are You Ready?

The submission is based on results from the Phase 3 AMPLITUDE study evaluating niraparib in combination with abiraterone acetate plus prednisone or prednisolone compared to a current standard of care,...